Literature DB >> 21765975

Role of Ikaros in T-cell acute lymphoblastic leukemia.

Philippe Kastner1, Susan Chan.   

Abstract

Ikaros is a zinc finger transcriptional regulator encoded by the Ikzf1 gene. Ikaros displays crucial functions in the hematopoietic system and its loss of function has been linked to the development of lymphoid leukemia. In particular, Ikaros has been found in recent years to be a major tumor suppressor involved in human B-cell acute lymphoblastic leukemia. Its role in T-cell leukemia, however, has been more controversial. While Ikaros deficiency appears to be very frequent in murine T-cell leukemias, loss of Ikaros appears to be rare in human T-cell acute lymphoblastic leukemia (T-ALL). We review here the evidence linking Ikaros to T-ALL in mouse and human systems.

Entities:  

Keywords:  Ikaros; Notch; T-cell leukemia

Year:  2011        PMID: 21765975      PMCID: PMC3135856          DOI: 10.4331/wjbc.v2.i6.108

Source DB:  PubMed          Journal:  World J Biol Chem        ISSN: 1949-8454


  54 in total

1.  Homozygous deletions and point mutations of the Ikaros gene in gamma-ray-induced mouse thymic lymphomas.

Authors:  H Okano; Y Saito; T Miyazawa; T Shinbo; D Chou; S Kosugi; Y Takahashi; S Odani; O Niwa; R Kominami
Journal:  Oncogene       Date:  1999-11-18       Impact factor: 9.867

2.  Radiation-associated loss of heterozygosity at the Znfn1a1 (Ikaros) locus on chromosome 11 in murine thymic lymphomas.

Authors:  Y Shimada; M Nishimura; S Kakinuma; M Okumoto; T Shiroishi; K H Clifton; S Wakana
Journal:  Radiat Res       Date:  2000-09       Impact factor: 2.841

3.  Expression of dominant-negative Ikaros isoforms in T-cell acute lymphoblastic leukemia.

Authors:  L Sun; M L Crotty; M Sensel; H Sather; C Navara; J Nachman; P G Steinherz; P S Gaynon; N Seibel; C Mao; A Vassilev; G H Reaman; F M Uckun
Journal:  Clin Cancer Res       Date:  1999-08       Impact factor: 12.531

4.  Dominant negative isoform of the Ikaros gene in patients with adult B-cell acute lymphoblastic leukemia.

Authors:  K Nakase; F Ishimaru; N Avitahl; H Dansako; K Matsuo; K Fujii; N Sezaki; H Nakayama; T Yano; S Fukuda; K Imajoh; M Takeuchi; A Miyata; M Hara; M Yasukawa; I Takahashi; H Taguchi; K Matsue; S Nakao; Y Niho; K Takenaka; K Shinagawa; K Ikeda; K Niiya; M Harada
Journal:  Cancer Res       Date:  2000-08-01       Impact factor: 12.701

5.  Ikaros is critical for B cell differentiation and function.

Authors:  Peggy Kirstetter; Mireille Thomas; Andrée Dierich; Philippe Kastner; Susan Chan
Journal:  Eur J Immunol       Date:  2002-03       Impact factor: 5.532

6.  Spectrum of Znfn1a1 (Ikaros) inactivation and its association with loss of heterozygosity in radiogenic T-cell lymphomas in susceptible B6C3F1 mice.

Authors:  Shizuko Kakinuma; Mayumi Nishimura; Syun-Ichi Sasanuma; Kazuei Mita; Gen Suzuki; Yoshimoto Katsura; Toshihiko Sado; Yoshiya Shimada
Journal:  Radiat Res       Date:  2002-03       Impact factor: 2.841

7.  Perturbation of Ikaros isoform selection by MLV integration is a cooperative event in Notch(IC)-induced T cell leukemogenesis.

Authors:  Levi J Beverly; Anthony J Capobianco
Journal:  Cancer Cell       Date:  2003-06       Impact factor: 31.743

8.  Widespread failure of hematolymphoid differentiation caused by a recessive niche-filling allele of the Ikaros transcription factor.

Authors:  Peter Papathanasiou; Andrew C Perkins; Bradley S Cobb; Roger Ferrini; Rupa Sridharan; Gerard F Hoyne; Keats A Nelms; Stephen T Smale; Christopher C Goodnow
Journal:  Immunity       Date:  2003-07       Impact factor: 31.745

9.  Overexpression of dominant-negative Ikaros 6 protein is restricted to a subset of B common adult acute lymphoblastic leukemias that express high levels of the CD34 antigen.

Authors:  Cécile Tonnelle; Marie-Christine Imbert; Danielle Sainty; Samuel Granjeaud; Catherine N'Guyen; Christian Chabannon
Journal:  Hematol J       Date:  2003

10.  Pre-T cell receptor (TCR) and TCR-controlled checkpoints in T cell differentiation are set by Ikaros.

Authors:  S Winandy; L Wu; J H Wang; K Georgopoulos
Journal:  J Exp Med       Date:  1999-10-18       Impact factor: 14.307

View more
  23 in total

1.  T-ALL can evolve to oncogene independence.

Authors:  Hesham Abdulla; Anh Vo; Benjamin J Shields; Tenae J Davies; Jacob T Jackson; Raed Alserihi; Elizabeth M Viney; Tin Wong; Feng Yan; Nicholas C Wong; Lisa Demoen; David J Curtis; Warren S Alexander; Pieter Van Vlierberghe; Ross A Dickins; Matthew P McCormack
Journal:  Leukemia       Date:  2021-01-22       Impact factor: 11.528

Review 2.  The role of zinc and its compounds in leukemia.

Authors:  Alexey P Orlov; Marina A Orlova; Tatiana P Trofimova; Stepan N Kalmykov; Dmitry A Kuznetsov
Journal:  J Biol Inorg Chem       Date:  2018-02-28       Impact factor: 3.358

3.  Ikaros in hematopoiesis and leukemia.

Authors:  Sinisa Dovat
Journal:  World J Biol Chem       Date:  2011-06-26

4.  Nbn-Mre11 interaction is required for tumor suppression and genomic integrity.

Authors:  Jun Hyun Kim; Alexander V Penson; Barry S Taylor; John H J Petrini
Journal:  Proc Natl Acad Sci U S A       Date:  2019-07-08       Impact factor: 11.205

5.  Cell cycle-specific function of Ikaros in human leukemia.

Authors:  Zhanjun Li; Chunhua Song; Hongsheng Ouyang; Liangxue Lai; Kimberly J Payne; Sinisa Dovat
Journal:  Pediatr Blood Cancer       Date:  2011-11-21       Impact factor: 3.167

Review 6.  Illegitimate V(D)J recombination involving nonantigen receptor loci in lymphoid malignancy.

Authors:  Masahiro Onozawa; Peter D Aplan
Journal:  Genes Chromosomes Cancer       Date:  2012-02-15       Impact factor: 5.006

Review 7.  Molecular basis of Klotho: from gene to function in aging.

Authors:  Yuechi Xu; Zhongjie Sun
Journal:  Endocr Rev       Date:  2015-02-19       Impact factor: 19.871

8.  Function of Ikaros as a tumor suppressor in B cell acute lymphoblastic leukemia.

Authors:  Philippe Kastner; Arnaud Dupuis; Marie-Pierre Gaub; Raoul Herbrecht; Patrick Lutz; Susan Chan
Journal:  Am J Blood Res       Date:  2013-01-17

9.  ARID5B and IKZF1 variants, selected demographic factors, and childhood acute lymphoblastic leukemia: a report from the Children's Oncology Group.

Authors:  Amy M Linabery; Crystal N Blommer; Logan G Spector; Stella M Davies; Leslie L Robison; Julie A Ross
Journal:  Leuk Res       Date:  2013-05-18       Impact factor: 3.156

10.  Activated Notch counteracts Ikaros tumor suppression in mouse and human T-cell acute lymphoblastic leukemia.

Authors:  M T Witkowski; L Cimmino; Y Hu; T Trimarchi; H Tagoh; M D McKenzie; S A Best; L Tuohey; T A Willson; S L Nutt; M Busslinger; I Aifantis; G K Smyth; R A Dickins
Journal:  Leukemia       Date:  2015-02-06       Impact factor: 11.528

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.